Navigation Links
Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
Date:2/19/2013

eliver the active drug, ketoprofen, a non-steroidal anti-inflammatory drug, through the skin directly into the underlying tissues where the drug exerts its localized anti-inflammatory and analgesic effects. We intend to leverage the Accudel platform technology to expand and create a portfolio of topical products for a variety of indications.  For more information, visit http://imprimispharma.com/.

This press release contains forward looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward looking statements." Forward looking statements are based on management's current preliminary expectations and are subject to risks and uncertainties which may cause our results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include our ability to raise additional funding, our ability to acquire, develop or commercialize new products and to enter into strategic alliances and transactions, uncertainties inherent in pre-clinical studies and clinical trials, unexpected new data, safety and technical issues, competition and market conditions. These and additional risks and uncertainties are more fully described in Imprimis' filings with the Securities and Exchange Commission. Undue reliance should not be placed on forward looking statements, which speak only as of the date they are made. Except as required by law, Imprimis undertakes no  obligation to update any forward looking statements to reflect new information, events or circumstances after the date they are made, or to reflect the occurrence of unanticipated events.

Contact: Mark L. Baum
Imprimis Pharmaceuticals, Inc.
(858) 433-2800


'/>"/>
SOURCE Imprimis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
2. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
3. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
4. Imprimis Names Two Experts To Its Science And Regulatory Board
5. Imprimis to Begin New Study of Its Topical Analgesic Drug
6. Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common Stock
7. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
8. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
9. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
10. Misonix Announces New Distribution Agreement For Panama
11. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 Woodford Patient Capital ... Trust and the Bill & Melinda Gates Foundation ... a leading monoclonal antibody biopharmaceutical company, announced today ... million to complete a US$90 million Series B ... Woodford Patient Capital Trust plc (LSE:WPCT,"Woodford") and Malin ...
(Date:5/5/2015)... , May 6, 2015 The ... lead the European market in the segment of animal ... alliance ECUPHAR acquires all the assets of Esteve Veterinary ... in the coming weeks. Being both private companies, the ...      (Photo: http://photos.prnewswire.com/prnh/20150506/743274 ) , ...
(Date:5/5/2015)... , May 5, 2015  In line with CBME ... to the community with a charity program to create ... autism. CBME China team is coordinating ... and maternity manufacturers, brand owners and distributors. All donated ... July 2015. Proceeds from the sale will be used ...
Breaking Medicine Technology:Kymab Secures US$90 Million Funding 2Kymab Secures US$90 Million Funding 3Kymab Secures US$90 Million Funding 4ECUPHAR Enters the Spanish and Southern European Markets Through ESTEVE 2CBME China Launches Charity Program to Support Children with Autism 2
... 2011 Researchers from Australia have identified ... factor for Autism Spectrum Disorders.  Pink disease was common in ... illness affecting children between the ages of eighteen months and ... irritability, and progressive loss of speech, symptoms very similar to ...
... CENTENNIAL, Colo., Aug. 9, 2011 AlloSource, a ... soft-tissue allografts for use in surgical procedures around ... with the Alliance for Regenerative Medicine (ARM) and ... membership with both organizations in order to support ...
Cached Medicine Technology:Familial Susceptibility to Mercury is a Risk Factor for Autism 2AlloSource Joins Alliance for Regenerative Medicine, Medical Device Manufacturers Association 2AlloSource Joins Alliance for Regenerative Medicine, Medical Device Manufacturers Association 3
(Date:5/6/2015)... 2015 Wolters Kluwer , a ... students, announced today that in a survey of nearly ... of the clinical decision support resource improves the quality ... 2014, UpToDate users in more than 170 countries worldwide ... on average. In Germany alone, 95% of all university ...
(Date:5/6/2015)... 06, 2015 Healthcare jobs ... after launching in mid-February. The company connects hospitals, home-health, ... previous experience in the industry. Likewise, job seekers are ... to Kyle Johnson, CTO, unique traffic to the site ... month: "Each new job posting brings targeted, interested candidates ...
(Date:5/6/2015)... Locally owned, Greek olive oil producer and importer, Our Family’s ... one the best Extra Virgin Olive Oils in the world. ... Greece and known as Laconiko , received the ... Oil, which is defined by the competition as “the perfect ... applicants from 25 different countries applying, Laconiko stood out as ...
(Date:5/6/2015)... 06, 2015 Dr. Vito C. Quatela, one ... , recently completed a medical mission trip to Hanoi, Vietnam ... those affected by microtia and other deformities of the face. ... and ended on April 26, Dr. Quatela and his team ... a congenital deformity where the outside of the ear is ...
(Date:5/6/2015)... Los Angeles, California (PRWEB) May 06, 2015 ... has secured its first round of VC funding and ... , The enterprise class embeddable software enables applications ... transform data as it moves between systems and locations. ... the HyperTransfer technology moves files at line speed, independent ...
Breaking Medicine News(10 mins):Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2Health News:Greek Extra Virgin Olive Oil, Laconiko Wins Gold at the NYIOOC and Is Featured in Olive Oil Times as One of Greece's Best EVOO's for 2015 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 3Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 2Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 3Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 4
... New study says that how much we drink may be ... revealed that the gene called DRD2 Taq1A(C32806T) polymorphism and social ... people with a stronger gene of this type will tend ... of this gene. The gene is responsible for enhancing the ...
... study, the drug perindopril used in early treatment of ... onset and progress of left ventricle dysfunction. ... muscular dystrophies that are characterized by muscle enlargement and ... is linked with the X-chromosomes and thus affects male ...
... A research which examined the tobacco byproducts in the ... been fooling // themselves by thinking that they are ... cigarettes. ,No significant difference was found in ... regardless of the type of cigarettes they smoked nor ...
... recent study in the journal Health and Place says that mercury ... of the reasons // of rise in number of autistic children. ... of the power plants that consume coal. According to the researchers, ... into the environment, there is a 61% increase in the rate ...
... E seemed to suggest that supplementing the diet with ... //Recently, a study published In Journal Of American Medical ... may be something very different. ,The researchers ... Prevention Evaluation or HOPE centers between 1993 and 1999, ...
... the apex medical body warns the people of South East ... bird flu virus in the area. It has also ... information to WHO regarding new cases of the disease. The ... closeness in occurrence in time and place is important to ...
Cached Medicine News:
... BALLARD Adult TRACH CARE Double Swivel ... patients. Dual swivels provide flexibility without ... and tactile sleeve for better feel. ... the distance of catheter advance. Offers ...
... KIMBERLY-CLARK BALLARD Adult ... designed for endotracheal intubated ... Features clear T-Piece, lavage/irrigation ... port. Offers multiple tracheostomy ...
... Our soft, flexible whistle tip suction ... kit that includes: One pair of ... 120 ml bottle of sterile saline. ... use with cuffed gloves and catheter ...
... Irri-Cath® catheters help decrease the need ... alternative to fiber-optic bronchoscope for bronchial ... in opportunistic infections., ,All Portex® ... ,The Irri-Cath® suction system ...
Medicine Products: